https://www.thebodypro.com/author/david-alain-wohl

Latest by David Alain Wohl, M.D.

Promo Image

Evolving Options for First-Line Therapy: Highlights From ICAAC/IDSA 2008

Table of Contents

Introduction Something New: Raltegravir Vs. Efavirenz Something Old: Three Updated Head-to-Head Trials

ARTEMIS Study: Lopinavir/Ritonavir Vs. Ritonavir-Boosted Darunavir CASTLE Study: Lopinavir/Ritonavir Vs. Ritonavir-Booste...

Promo Image

First-Line HIV Therapy and Treatment Strategies: A Summary of Key CROI 2008 Research

Table of Contents

Introduction Atazanavir Versus Lopinavir/Ritonavir Abacavir/Lamivudine Versus Tenofovir/Emtricitabine Efavirenz Versus Maraviroc Maraviroc Concentrations in the Female Genital Tract An Analysis of the Effect of Baseline F...

Promo Image

Complications of HIV/HAART: A Summary of Key CROI 2008 Research

Table of Contents

Introduction Low-Dose Growth Hormone in Patients With Lipodystrophy When Does Fat Loss Become Clinically Evident? Chromium Supplementation and Fat Loss HIV and Cardiovascular Problems HIV and Inflammation in STACCATO Ag...

Promo Image
Lipodystrophy/Body Fat

Metabolic Complications Myths

Introduction Myth #1: Protease inhibitors are responsible for the increases in belly fat. Myth #2: People who get bigger bellies on HIV meds typically also lose fat in their arms and legs. Myth #3: Loss of limb fat during HIV therapy only occ...

Promo Image

Current Options for First-Line Treatment of HIV Infection

Table of Contents

Part I: Strategies for First-Line Therapy

Introduction Choosing Among Drug Classes Efavirenz-Based Combinations Ritonavir-Boosted PI-Based Regimens Considering NRTIs The Horizon Putting It All Together References

Pa...

Promo Image

Current Options for First-Line Treatment of HIV Infection

Table of Contents

Part I: Strategies for First-Line Therapy

Part II: Case Studies

Case 1. The Apprehensive Teller Case 2. Advanced AIDS, TB and Treatment Naive Reference

Case 1. The Apprehensive Teller

Presentation

Marilyn is a 41-year-old ...

Promo Image

Top 10 HIV Medical Stories of 2006

Table of Contents

Introduction

Top 10 Medical Stories of 2006:

The SMART Study -- A Treatment Interruption Trial
    CD4+ count-guided interruption of antiretroviral treatment
    By the Strategies for Management of Antiretroviral Ther...
Promo Image
Incarcerated People

Spotlight: Interventions to Reduce HIV and STD Transmission Risk Behaviors Following Prison Release -- A Conversation With Dr. Richard Wolitski

The results of the START Study, a randomized controlled trial of interventions to reduce HIV/STD risk behaviors among 522 young men being released from prison in four states (California, Mississippi, Rhode Island and Wisconsin), were recently publish...

Promo Image
Conference Coverage

Metabolic Complications at the XVI International AIDS Conference: Part 2 -- Lipids

For Part 1 of this report, click here.

Although there remains controversy regarding the degree to which HIV-infected people are at greater risk for cardiovascular disease (CVD) and whether it is HIV or highly active antiretroviral therapy (HAART) th...

Promo Image
Conference Coverage

Metabolic Complications at the XVI International AIDS Conference: Part 1 -- An Overview of New Data

For Part 2 of this report, click here.

The International AIDS Conference, formerly known as the World AIDS Conference, was at one time the premier venue for the presentation of new data related to the pathogenesis, epidemiology, prevention and treat...